Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BEL FUSE INC /NJBELFB · Entity 2749 | Director | March 15, 2025 | March 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BEL FUSE INC /NJ
Report date March 15, 2025 · Filed March 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table I · non-derivative | Direct | 4,552 |
Reported balance
After 2025-03-15 transaction · row 1
1 source rowRow 1 · 2025-03-15 · Grant · Acquired 307 · Balance 4,552 F1: Ms. Brito was granted 307 restricted shares of Class B Common Stock on March 15, 2025. The restricted shares vest as follows: 102 shares vest as of March 15, 2026; 102 shares vest as of March 15, 2027; and 103 shares vest as of March 15, 2028. |
Filing footnotes · ownership attribution and instrument terms
F1: Ms. Brito was granted 307 restricted shares of Class B Common Stock on March 15, 2025. The restricted shares vest as follows: 102 shares vest as of March 15, 2026; 102 shares vest as of March 15, 2027; and 103 shares vest as of March 15, 2028.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2025 Filed Mar 18, 2025 17:22 UTC | BEL FUSE INC /NJ BELFB · Entity 2749 | GrantClass B Common Stock | 307 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-008192 · rdgdoc.xml · nonDerivative · entry 1 Brito Jacqueline T. · CIK 0001892334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,552 F1 · shares: Ms. Brito was granted 307 restricted shares of Class B Common Stock on March 15, 2025. The restricted shares vest as follows: 102 shares vest as of March 15, 2026; 102 shares vest as of March 15, 2027; and 103 shares vest as of March 15, 2028. Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 15:19 UTC | BEL FUSE INC /NJ BELFB · Entity 2749 | GrantClass B Common Stock | 245 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-001487 · rdgdoc.xml · nonDerivative · entry 1 Brito Jacqueline T. · CIK 0001892334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,245 F1 · shares: Ms. Brito was granted 245 restricted shares of Class B Common Stock on January 15, 2024. The restricted shares vest as follows: 81 shares vest as of January 15, 2025; 82 shares vest as of January 15, 2026; and 82 shares vest as of January 15, 2027. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 19:54 UTC | BEL FUSE INC /NJ BELFB · Entity 2749 | GrantClass B Common Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-020640 · doc1.xml · nonDerivative · entry 1 Brito Jacqueline T. · CIK 0001892334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F1 · shares: Ms. Brito was granted 4,000 restricted shares of Class B Common Stock on November 15, 2021. The restricted shares vest as follows: 1,000 shares vest as of November 15, 2023; 1,000 shares vest as of November 15, 2024; 1,000 shares vest as of November 15, 2025; and 1,000 shares vest as of November 15, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.